-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Royalty Pharma plc quarterly/annual Revenues history and growth rate from Q2 2019 to Q3 2024.
- Royalty Pharma plc Revenues for the quarter ending September 30, 2024 was $565M, a 5.29% increase year-over-year.
- Royalty Pharma plc Revenues for the twelve months ending September 30, 2024 was $2.27B, a 2.51% decline year-over-year.
- Royalty Pharma plc annual Revenues for 2023 was $2.35B, a 5.25% increase from 2022.
- Royalty Pharma plc annual Revenues for 2022 was $2.24B, a 2.28% decline from 2021.
- Royalty Pharma plc annual Revenues for 2021 was $2.29B, a 7.87% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)